Industry Veteran with Deep Pharmaceutical and Artificial Intelligence (AI) Expertise Strengthens Bridge Informatics’ Ability to Deliver Cutting-Edge Bioinformatics Solutions
BOSTON, MA– Bridge Informatics, a data science consultancy bridging the gap between biology and informatics in the life sciences industry, today announced the appointment of Richard Harrison PhD as its new Board of Directors member. With over 35 years of experience in pharmaceutical (pharma) research, AI-driven drug discovery, and consulting, Richard brings a wealth of expertise to the company.
“Bridge Informatics’ approach to single-cell analysis is the best I’ve seen, ” said Richard. “This focus on single-cell data is what sets them apart, as it represents the majority of their work. I’m excited about how they’re enabling single-cell experiments for clientele, truly unlocking the mysteries of biology through data science. I’m thrilled to support their mission of delivering unmatched bioinformatic solutions.”
“Richard’s extensive experience in preclinical drug discovery, coupled with his track record of delivering clinical candidates, aligns perfectly with Bridge Informatics’ mission to bridge the gap between genomic data and biological insight,” said Dan Ryder, Founder and Chief Executive Officer of Bridge Informatics.
Richard’s 30-year tenure at companies such as Merck, Aventis, and Novartis spans target identification through Phase I clinical trials. As a scientist on various research teams, Richard has been instrumental in delivering numerous clinical candidates and contributing to the success of several marketed drugs.
Richard’s leadership roles at AI-enabled drug discovery organizations, including AitiaBio, AcornAI, Causaly, and PercayAI, demonstrate his commitment to advancing innovative solutions. As a founding scientist in two biotech companies, he has been at the forefront of cutting-edge research. Additionally, Richard served as the Chief Scientific Officer at Thomson Reuters (now Clarivate Analytics), where he guided strategic initiatives and identified novel technologies.
For more information about Bridge Informatics, please visit www.bridgeinformatics.com. Follow the company on LinkedIn, X (formerly Twitter), and Facebook.
About Bridge Informatics
Bridge Informatics is a data science consultancy dedicated to translating data into biological results for life science companies. With expertise in machine learning, bioinformatics, data infrastructure, data mining, and software and database engineering, Bridge Informatics bridges the gap between biology and data science. The company’s unique approach provides clients with a team of talented data scientists who possess a strong background in biology and a passion for education and coaching, ensuring efficient and transparent communication. Founded on the principles of collaboration and understanding, Bridge Informatics empowers life science organizations to leverage their data for informed decision-making.
